Results 11 to 20 of about 2,653,429 (308)
Potential biochemical markers of chronic bronchitis
Бюллетень сибирской медицины, 2021 The review systematizes modern data on the biochemical markers that can clarify the nature and the course of chronic bronchitis. The article describes markers associated with bronchopulmonary pathology, such as tumor necrosis factor alpha (TNFα ...
E. A. Kurtukov, Yu. I. Ragino
doaj +1 more source
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
Frontiers in Immunology, 2023 ObjectivesRecent studies supported coagulation involvement in multiple sclerosis, an inflammatory-demyelinating and degenerative disease of the central nervous system. The main objectives of this observational study were to identify the most specific pro-
Tatiana Koudriavtseva +21 more
doaj +1 more source
Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
Frontiers in Bioengineering and Biotechnology, 2020 Blood-contacting medical devices of different biomaterials are often used to treat various cardiovascular diseases. Thrombus formation is a common cause of failure of cardiovascular devices.
Carlos A. Labarrere +2 more
doaj +1 more source
Angiogenesis in tissue engineering : Breathing life into constructed tissue substitutes [PDF]
, 2006 Long-term function of three-dimensional (3D) tissue constructs depends on adequate vascularization after implantation. Accordingly, research in tissue engineering has focused on the analysis of angiogenesis.
Germann, Gunter +17 more
core +1 more source
Thrombosis Journal, 2005 Background Thrombin generation assay was developed several years ago to mimic physiological coagulation mechanisms but it had important limitations. Thrombogram-Thrombinoscope assay using a fluorogenic substrate, allows obtaining thrombin generation ...
Leflem Lena +5 more
doaj +1 more source
Comparison of the coagulopathies associated with COVID‐19 and sepsis
Research and Practice in Thrombosis and Haemostasis, 2021 Background Coronavirus disease 2019 (COVID‐19) is associated with activation of coagulation that mainly presents as thrombosis. Sepsis is also associated with activation of coagulation that mainly presents as disseminated intravascular coagulation.
Robert A. Campbell +8 more
doaj +1 more source
Tissue factor and cancer [PDF]
Thrombosis Research, 2012 The hemostatic system is involved in multiple interactions with transformed cells that progress from a dormant, non-vascularized tumor to highly metastatic phenotypes. Oncogenic transformations up regulate not only the initiator of the coagulation cascade, tissue factor (TF), but also induce other molecules that are required for TF's direct cell ...
openaire +2 more sources
Research and Practice in Thrombosis and Haemostasis, 2022 Background Circulating tissue factor (TF)‐expressing extracellular vesicles (EVs) are associated with thrombosis in several diseases, such as coronavirus disease 2019 (COVID‐19). Activity assays have higher sensitivity and specificity compared to antigen
Sierra J. Archibald +3 more
doaj +1 more source
Journal of Cardiovascular Development and Disease, 2022 Background: Thrombosis with cardiovascular involvement is a crucial complication in COVID-19 infection. COVID-19 infects the host by the angiotensin converting enzyme-2 receptor (ACE2r), which is expressed in endothelial cells too.
Giovanni Cimmino +9 more
doaj +1 more source
Tissue Factor Encryption [PDF]
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006 Tissue factor (TF) encryption is the post-translational suppression of TF procoagulant activity (PCA) on the cell surface. There is emerging evidence of encrypted TF in normal blood associated with monocytes and platelets. Expression of this latent TF PCA during the propagation phase of blood coagulation may contribute to hemostasis.
openaire +2 more sources